Chemical andropause and amyloid-beta peptide.
Gandy
S
S
Almeida
O P
OP
Fonte
J
J
Lim
D
D
Waterrus
A
A
Spry
N
N
Flicker
L
L
Martins
R N
RN
D000230:Adenocarcinoma / Q000097:blood / Q000628:therapy; D000368:Aged; D000369:Aged, 80 and over; D000544:Alzheimer Disease / Q000097:blood*; D016229:Amyloid beta-Peptides / Q000097:blood*; D000726:Androgen Antagonists / Q000627:therapeutic use; D018931:Antineoplastic Agents, Hormonal / Q000627:therapeutic use; D004958:Estradiol / Q000097:blood*; D005485:Flutamide / Q000627:therapeutic use; D007987:Gonadotropin-Releasing Hormone / Q000819:agonists; D006801:Humans; D016729:Leuprolide / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D009376:Neoplasms, Hormone-Dependent / Q000097:blood / Q000628:therapy; D011471:Prostatic Neoplasms / Q000097:blood / Q000628:therapy; D013739:Testosterone / Q000097:blood*
D016229:Amyloid beta-Peptides; D000726:Androgen Antagonists; D018931:Antineoplastic Agents, Hormonal; D007987:Gonadotropin-Releasing Hormone; D013739:Testosterone; D004958:Estradiol; D005485:Flutamide; D016729:Leuprolide